158 related articles for article (PubMed ID: 24832355)
1. Synchronous luminescence spectroscopic characterization of urine of normal subjects and cancer patients.
Rajasekaran R; Aruna P; Koteeswaran D; Baludavid M; Ganesan S
J Fluoresc; 2014 Jul; 24(4):1199-205. PubMed ID: 24832355
[TBL] [Abstract][Full Text] [Related]
2. Characterization and diagnosis of cancer by native fluorescence spectroscopy of human urine.
Rajasekaran R; Aruna PR; Koteeswaran D; Padmanabhan L; Muthuvelu K; Rai RR; Thamilkumar P; Murali Krishna C; Ganesan S
Photochem Photobiol; 2013; 89(2):483-91. PubMed ID: 22971002
[TBL] [Abstract][Full Text] [Related]
3. High wavenumber Raman spectroscopy in the characterization of urinary metabolites of normal subjects, oral premalignant and malignant patients.
Brindha E; Rajasekaran R; Aruna P; Koteeswaran D; Ganesan S
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Jan; 171():52-59. PubMed ID: 27475997
[TBL] [Abstract][Full Text] [Related]
4. Discrimination among melanoma, nevi, and normal skin by using synchronous luminescence spectroscopy.
Zeković I; Dramićanin T; Lenhardt L; Bandić J; Dramićanin MD
Appl Spectrosc; 2014; 68(8):823-30. PubMed ID: 25061783
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence characteristics of human urine from normal individuals and ovarian cancer patients.
Zvarik M; Martinicky D; Hunakova L; Lajdova I; Sikurova L
Neoplasma; 2013; 60(5):533-7. PubMed ID: 23790172
[TBL] [Abstract][Full Text] [Related]
6. Steady-state and time-resolved fluorescence spectroscopic characterization of urine of healthy subjects and cervical cancer patients.
Rajasekaran R; Aruna PR; Koteeswaran D; Bharanidharan G; Baludavid M; Ganesan S
J Biomed Opt; 2014 Mar; 19(3):37003. PubMed ID: 24647974
[TBL] [Abstract][Full Text] [Related]
7. Investigation of urinary pteridine levels as potential biomarkers for noninvasive diagnosis of cancer.
Gamagedara S; Gibbons S; Ma Y
Clin Chim Acta; 2011 Jan; 412(1-2):120-8. PubMed ID: 20869359
[TBL] [Abstract][Full Text] [Related]
8. Native fluorescence spectroscopy of blood plasma in the characterization of oral malignancy.
Madhuri S; Vengadesan N; Aruna P; Koteeswaran D; Venkatesan P; Ganesan S
Photochem Photobiol; 2003 Aug; 78(2):197-204. PubMed ID: 12945589
[TBL] [Abstract][Full Text] [Related]
9. Three-dimensional total synchronous luminescence spectroscopy criteria for discrimination between normal and malignant breast tissues.
Dramićanin T; Dramićanin MD; Jokanović V; Nikolić-Vukosavljević D; Dimitrijević B
Photochem Photobiol; 2005; 81(6):1554-8. PubMed ID: 16149859
[TBL] [Abstract][Full Text] [Related]
10. Synchronous Luminescence Spectroscopy as a Tool in the Discrimination and Characterization of Oral Cancer Tissue.
Gnanatheepam E; Kanniyappan U; Dornadula K; Prakasarao A; Singaravelu G
J Fluoresc; 2019 Mar; 29(2):361-367. PubMed ID: 30675678
[TBL] [Abstract][Full Text] [Related]
11. [Determination of riboflavin in the urine of patients with malignant tumors].
KAGAN IaA
Khirurgiia (Mosk); 1960 Feb; 36():103-8. PubMed ID: 13853201
[No Abstract] [Full Text] [Related]
12. Differences in Spectroscopic Properties of Saliva Taken From Normal Subjects and Oral Cancer Patients: Comparison Studies.
Supawat B; Aye KT; Ritpanja J; Nueangwong W; Kothan S; Pan J; Tungjai M
J Fluoresc; 2021 May; 31(3):747-754. PubMed ID: 33638767
[TBL] [Abstract][Full Text] [Related]
13. Synchronous fluorescence spectroscopy for the detection and characterization of cervical cancers in vitro.
Ebenezar J; Aruna P; Ganesan S
Photochem Photobiol; 2010; 86(1):77-86. PubMed ID: 19845540
[TBL] [Abstract][Full Text] [Related]
14. [Normal and pathologic metabolism of pteridines in man].
Dhondt JL; Bellhasene Z; Largilliere C; Bonneterre J; Farriaux JP
LARC Med; 1982 May; 2(5):431-3. PubMed ID: 7167018
[No Abstract] [Full Text] [Related]
15. Pteridine detection in urine: the future of cancer diagnostics?
Ma Y; Burton C
Biomark Med; 2013 Oct; 7(5):679-81. PubMed ID: 24044558
[No Abstract] [Full Text] [Related]
16. [Urinary riboflavin in animals with implanted tumors].
KAGAN IaA
Vopr Onkol; 1955; 1(3):88-91. PubMed ID: 13299800
[No Abstract] [Full Text] [Related]
17. Cancer detection by native fluorescence of urine.
Masilamani V; Vijmasi T; Al Salhi M; Govindaraj K; Vijaya-Raghavan AP; Antonisamy B
J Biomed Opt; 2010; 15(5):057003. PubMed ID: 21054119
[TBL] [Abstract][Full Text] [Related]
18. Characterization and classification of pathogenic bacteria using native fluorescence and spectral deconvolution.
Sundaramoorthy A; Bharanidharan G; Prakasarao A; Ganesan S
J Biophotonics; 2024 Jun; ():e202300566. PubMed ID: 38847123
[TBL] [Abstract][Full Text] [Related]
19. Investigation of urinary volatile organic metabolites as potential cancer biomarkers by solid-phase microextraction in combination with gas chromatography-mass spectrometry.
Silva CL; Passos M; Câmara JS
Br J Cancer; 2011 Dec; 105(12):1894-904. PubMed ID: 22085842
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous detection of six urinary pteridines and creatinine by high-performance liquid chromatography-tandem mass spectrometry for clinical breast cancer detection.
Burton C; Shi H; Ma Y
Anal Chem; 2013 Nov; 85(22):11137-45. PubMed ID: 24138137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
